KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Louisiana

HB761 • 2026

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Stephanie Hilferty
Last action
2026-06-08
Official status
Signed by the Governor - Act 832
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

What This Bill Does

  • HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Filed

Plain English: SSHB761 4902 6254 HOUSE SUMMARY OF SENATE AMENDMENTS HB 761 2026 Regular Session Hilferty HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers Synopsis of Senate Amendments 1.

  • SSHB761 4902 6254 HOUSE SUMMARY OF SENATE AMENDMENTS HB 761 2026 Regular Session Hilferty HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers Synopsis of Senate Amendments 1.
  • Extends the deadline for submitting written reports from 30 days to 45 days following each meeting.
  • 2.
  • Makes technical changes.
Adopted

Plain English: HFAHB761 4902 3754 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Hilferty to Engrossed House Bill No.

  • HFAHB761 4902 3754 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Hilferty to Engrossed House Bill No.
  • 761 by Representative Hilferty 1 AMENDMENT NO.
  • 1 2 On page 1, delete line 4 in its entirety and insert in lieu thereof the following: 3 "and reporting; to provide for effectiveness; and to provide for related matters." 4 AMENDMENT NO.
  • 2 5 On page 1, line 18, after "designee of" delete the remainder of the line and insert in lieu 6 thereof the following: 7 "The Cancer Association of Louisiana." 8 AMENDMENT NO.
Filed

Plain English: 2026 Regular Session Sequence: 1737 HBS AMENDED BY SENATE TO BE CONCURRED IN HB 761 BY HILFERTY CONCUR IN SENATE AMENDMENTS Date: 5/29/2026 Time: 1:41:53 PM ROLL CALL The roll was called with the following result: YEAS Adams Amedee Bacala Bamburg Beaullieu Berault Billings Boudreaux Bourriaque Boyd Boyer Brass Braud Broussard Bryant Butler Carlson Carrier Carter, R.

  • 2026 Regular Session Sequence: 1737 HBS AMENDED BY SENATE TO BE CONCURRED IN HB 761 BY HILFERTY CONCUR IN SENATE AMENDMENTS Date: 5/29/2026 Time: 1:41:53 PM ROLL CALL The roll was called with the following result: YEAS Adams Amedee Bacala Bamburg Beaullieu Berault Billings Boudreaux Bourriaque Boyd Boyer Brass Braud Broussard Bryant Butler Carlson Carrier Carter, R.
  • Carter, W.
  • Carver Chassion Chenevert Coates Cox Crews Deshotel Dewitt Dickerson Domangue Echols Edmonston Egan Farnum Firment Fisher Fontenot Freeman Freiberg Gadberry Galle Geymann Glorioso Green Hebert Henry, C.
  • Henry, D.
Adopted

Plain English: SCAHB761 3275 4485 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.

  • SCAHB761 3275 4485 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.
  • 761 by Representative Hilferty 1 AMENDMENT NO.
  • 1 2 On page 2, at the beginning of line 2, change "The" to "the" 3 AMENDMENT NO.
  • 2 4 On page 2, line 16, after "chairperson." change "Within" to "Within" 5 AMENDMENT NO.
Draft

Plain English: SCAHB761 3275 4437 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.

  • SCAHB761 3275 4437 SENATE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by Senate Committee on Insurance to Reengrossed House Bill No.
  • 761 by Representative Hilferty 1 AMENDMENT NO.
  • 1 2 On page 2, at the beginning of line 2, change "The" to "the" 3 AMENDMENT NO.
  • 2 4 On page 2, line 16, after "chairperson." change "Within" to "Within" 5 AMENDMENT NO.

Bill History

  1. 2026-06-08 H

    Effective date: 06/08/2026.

  2. 2026-06-08 H

    Signed by the Governor. Becomes Act No. 832.

  3. 2026-06-01 H

    Sent to the Governor for executive approval.

  4. 2026-06-01 S

    Signed by the President of the Senate.

  5. 2026-05-31 H

    Enrolled and signed by the Speaker of the House.

  6. 2026-05-29 H

    Read by title, roll called, yeas 100, nays 0, Senate amendments concurred in.

  7. 2026-05-29 H

    Scheduled for concurrence on 05/29/2026.

  8. 2026-05-28 H

    Received from the Senate with amendments.

  9. 2026-05-28 S

    The amended bill was read by title, passed by a vote of 34 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

  10. 2026-05-27 S

    Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

  11. 2026-05-27 S

    Rules suspended. Reported with amendments. Rules suspended. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.

  12. 2026-04-20 S

    Read second time by title and referred to the Committee on Insurance.

  13. 2026-04-15 S

    Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

  14. 2026-04-14 H

    Read third time by title, amended, roll called on final passage, yeas 98, nays 0. Finally passed, title adopted, ordered to the Senate.

  15. 2026-04-13 H

    Scheduled for floor debate on 04/14/2026.

  16. 2026-04-09 H

    Read by title, ordered engrossed, passed to 3rd reading.

  17. 2026-04-08 H

    Reported favorably (12-0).

  18. 2026-03-09 H

    Read by title, under the rules, referred to the Committee on Insurance.

  19. 2026-02-27 H

    First appeared in the Interim Calendar on 2/27/2026.

  20. 2026-02-27 H

    Under the rules, provisionally referred to the Committee on Insurance.

  21. 2026-02-27 H

    Prefiled.

Official Summary Text

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

Current Bill Text

Read the full stored bill text 
ENROLLED
ACT No. 8322026 Regular Session
HOUSE BILL NO. 761
BY REPRESENTATIVES HILFERTY, ADAMS, BAYHAM, BILLINGS, WILFORD
CARTER, CHASSION, FISHER, GREEN, LACOMBE, LAFLEUR, TERRY
LANDRY, LARVADAIN, MARCELLE, MARTINEZ, PHELPS, SPELL,
TAYLOR, WALTERS, AND ZERINGUE
1 AN ACT
2 To amend and reenact R.S. 22:1076.1, relative to the advisory board for rare cancer
3 treatments; to provide for revisions to board composition; to provide for meetings
4 and reporting; to provide for effectiveness; and to provide for related matters.
5 Be it enacted by the Legislature of Louisiana:
6 Section 1. R.S. 22:1076.1 is hereby amended and reenacted to read as follows:
7 §1076.1. Advisory board; composition; recommendations for treatment of rare
8 cancers; meetings; rulemaking
9 A. There is hereby created within the department an advisory board that shall
10 review and provide medical recommendations to approve new treatments for rare
11 cancers. The advisory board shall be composed of the following seventeen
12 members:
13 (1) The commissioner or his designee.
14 (2) The secretary or designee of the Louisiana Department of Health.
15 (3) The Medicaid Director or designee of the Louisiana Department of
16 Health.
17 (4) The surgeon general or his designee.
18 (5) The executive director or designee of Taking Aim at Cancer in Louisiana
19 the Cancer Association of Louisiana.
20 (6) The chief executive officer of the Louisiana Association of Health Plans.
21 (7) The chief medical officer or designee of a managed care organization.
22 (8) The director or designee of the Louisiana Tumor Registry.
23 (9) The director or designee of the Pennington Biomedical Research Center.
24 (10) A designee of the Louisiana Cancer Research Center.
Page 1 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 761 ENROLLED
1 (11) A designee of the LSU Health Sciences Center at New Orleans,
2 specializing in oncology.
3 (12) A designee of the Tulane Medical School, specializing in oncology.
4 (13) A designee of the Xavier Ochsner College of Medicine.
5 (14) Two Four oncologists specializing in the treatments of rare cancers.
6 B.(1) The chairperson of the advisory board shall be the executive director
7 or designee of the Louisiana Cancer Research Center.
8 (2) The advisory board shall hold quarterly public meetings unless otherwise
9 provided by vote of the advisory board or by order of the chairperson. Within thirty
10 No later than forty-five days of after each meeting, the advisory board shall compile
11 a report of its findings and submit a formal written report to the legislature House
12 Committee on Insurance and the Senate Committee on Insurance.
13 C. The commissioner may promulgate and adopt administrative rules and
14 regulations in accordance with the Administrative Procedure Act as are necessary to
15 implement the provisions of this Section.
16 Section 2. This Act shall become effective upon signature by the governor or, if not
17 signed by the governor, upon expiration of the time for bills to become law without signature
18 by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana. If
19 vetoed by the governor and subsequently approved by the legislature, this Act shall become
20 effective on the day following such approval.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 2 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.